Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma

NCT03061656 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

High Risk Neuroblastoma

Interventions

DRUG: Cyclophosphamide
DRUG: Carboplatin
DRUG: Etoposide
RADIATION: 131I-MIBG
DRUG: Thiotepa
DRUG: Melphalan

Sponsor

Samsung Medical Center

Collaborators

[object Object]